This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo

Dicycloverine hydrochloride oral

Updated 2 Feb 2023 | Antimuscarinics

Presentation

Oral formulations of dicycloverine hydrochloride.

Drugs List

  • dicycloverine 10mg tablets
  • dicycloverine 10mg/5ml oral solution
  • dicycloverine 10mg/5ml oral solution sugar-free
  • dicycloverine 20mg tablets
  • Therapeutic Indications

    Uses

    Adjunct in gastric smooth muscle spasm

    Dosage

    Adults

    10 to 20mg three times per day.

    Children

    Dicycloverine is contraindicated in infants under 6 months of age.

    Children aged 12 to 18 years
    10 to 20mg three times per day.

    Children aged 2 to 12 years
    10mg three times per day.

    Children aged 6 months to 2 years
    5 to 10mg three to four times per day.
    Give 15 minutes before feeds. Maximum daily dose of 40mg.

    Contraindications

    Children under 6 months
    Myasthenia gravis
    Paralytic ileus
    Pyloric stenosis
    Toxic megacolon

    Precautions and Warnings

    Diarrhoea
    Down's syndrome
    Elderly
    Predisposition to narrow angle glaucoma
    Pyrexia
    Autonomic neuropathy
    Benign prostatic hyperplasia
    Breastfeeding
    Cardiac impairment
    Cardiac surgery
    Galactosaemia
    Glucose-galactose malabsorption syndrome
    Hereditary fructose intolerance
    Hiatus hernia
    Hypertension
    Hyperthyroidism
    Lactose intolerance
    Myocardial infarction
    Narrow angle glaucoma
    Pregnancy
    Reflux oesophagitis
    Tachycardia
    Ulcerative colitis

    Some formulations contain glucose
    Some formulations contain lactose
    Some formulations contain sucrose

    Pregnancy and Lactation

    Pregnancy

    Use dicycloverine with caution during pregnancy.

    The manufacturer recommends that dicycloverine is not used in pregnancy unless the potential benefit to the mother outweighs the potential risk to the foetus. Animal studies have demonstrated no evidence of impaired fertility or adverse foetal effects with dicycloverine. Epidemiological studies on the use of dicycloverine in human pregnancies have also indicated that dicycloverine hydrochloride does not appear to increase the risk of foetal abnormalities if administered during the first trimester of pregnancy.

    Lactation

    Use dicycloverine with caution during breastfeeding.

    The manufacturer recommends that caution is exercised when dicycloverine is administered during breastfeeding and state that it is unknown whether dicycloverine is secreted in human milk.

    Side Effects

    Anorexia
    Arrhythmias
    Blurred vision
    Bradycardia
    Confusion
    Constipation
    Decreased bronchial secretions
    Difficulty in micturition
    Dilatation of pupils
    Disturbances in accommodation
    Dizziness
    Dry mouth
    Dry skin
    Dysuria
    Fatigue
    Flushing
    Giddiness
    Glaucoma (closed angle)
    Headache
    Nausea
    Palpitations
    Photophobia
    Rash
    Sedation
    Tachycardia
    Thirst
    Urinary retention
    Urinary urgency
    Vomiting

    Overdosage

    It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.

    The following number will direct the caller to the relevant local centre (0844) 892 0111

    Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).

    Further Information

    Last Full Review Date: August 2014

    Reference Sources

    Summary of Product Characteristics: Dicycloverine 10mg tablets. Zentiva. Revised April 2014.

    Summary of Product Characteristics: Dicycloverine 10mg/5ml oral solution. Zentiva. Revised May 2014.

    Summary of Product Characteristics: Dicycloverine 20mg tablets. Zentiva. Revised April 2014.

    Summary of Product Characteristics: Dicycloverine Hydrochloride 10mg/5ml Oral Solution. Noumed Life Sciences Limited. Revised October 2019.

    NICE Evidence Services Available at: www.nice.org.uk Last accessed: 08 September 2022

    Access the full UK drug database with a FREE Medscape UK Account
    It takes just a few minutes, and you’ll get unlimited access to information on over 11,000 UK drugs.
    Register for Free

    Already a member? Log in

    Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content

    FDB Logo

    FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.